Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Poor fruit, vegetable intake responsible for millions of CV deaths

Inadequate fruit and vegetable consumption contributes to nearly 2 million CV-related deaths each year, according to research presented at Nutrition 2019, the American Society for Nutrition’s annual meeting, in Baltimore.

Thumbnail

UNC Children’s suspends complex heart surgeries amid investigation

North Carolina Children’s Hospital will be suspending heart surgeries for its most complex cases for the time being—a direct response to a New York Times investigation that called into question the safety of practices in the center’s pediatric heart surgery unit—the Times reported June 17.

Thumbnail

BP drug nilvadipine could benefit Alzheimer’s patients

The antihypertensive drug nilvadipine may benefit Alzheimer’s patients by encouraging blood flow to the brain, slowing the progression of the disease while reducing blood pressure in the hippocampus, researchers reported in Hypertension June 17.

Thumbnail

Are Americans prone to heart attack during vacation?

With a recent rise in heart-attack related deaths among Americans vacationing overseas, one domestic cardiologist is speaking up about CV health while traveling.

Thumbnail

Sauna visits affect BP, heart rate like moderate exercise

A 25-minute steam in the sauna could be just as beneficial for heart health as a moderate physical workout, researchers at Martin Luther University Halle-Wittenberg and the Medical Center Berlin have found.

Transcarotid access: The future of non-femoral TAVR?

Research presented at TVT 2019 in Chicago last week suggests a transcarotid approach to transcatheter aortic valve replacement is favorable for patients unable to tolerate femoral access, topping both transapical and transaortic approaches as the preferable route for alternate-access TAVR.  

Thumbnail

Why the next TAVR vs. SAVR trial should be in bicuspid AS patients

Physicians are facing a new issue as TAVR expands to younger populations—an increased incidence of bicuspid aortic stenosis.

‘Our patients are worth it’: Tackling the undertreatment of aortic stenosis in the US

The undertreatment of aortic stenosis in the U.S. is severe, driven by deep-rooted racial and sex disparities and a disconnect between patients and their clinicians.